ALTSCHULLER Susan
Chief Financial Officer at Cerevel Therapeutics Holdings, Inc.; Officer at ImmunoGen, Inc.
- Sold, on record
- $572k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Dec 20, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Cerevel Therapeutics Holdings, Inc.Chief Financial Officer
- ImmunoGen, Inc.Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice ImmunoGen, Inc.NoticeMay 5, 2023 2023
Filed to sell 475,696 shares ($6.3M)
ALTSCHULLER Susan, Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale Cerevel Therapeutics Holdings, Inc.UnusualDec 20, 2023 +229 days
Sold 13,808 shares at $41.42 ($572k)
ALTSCHULLER Susan, Chief Financial Officer
No 10b5-1 planSold 44.9% of holdings ($1.3M position)16,913 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2023 | Dec 21, 2023 | Cerevel Therapeutics Holdings, Inc. | Chief Financial Officer | Form 4 sale | 13,808 | $572k | 44.9% | Unusual | SEC |
| May 5, 2023 | May 5, 2023 | ImmunoGen, Inc. | Officer | Form 144 notice | 475,696 | $6.3M | Notice | SEC |